ABSTRACT
Osteoarthritis prevalence is expected to increase markedly in the Asia-Pacific region due to rapid population aging. Identifying effective and safe therapeutic options to manage osteoarthritic pain is viewed as a priority. The Asia-Pacific Experts on Topical Analgesics Advisory Board developed consensus statements for use of topical NSAIDs in musculoskeletal pain. Evidence supporting these statements in osteoarthritic pain was reviewed. Best available evidence indicates that topical NSAIDs have a moderate effect on relief of osteoarthritic pain, comparable to that of oral NSAIDs but with a better risk-to-benefit ratio. International clinical practice guidelines recommend topical NSAIDs on par with or ahead of oral NSAIDs for pain management in patients with knee and hand osteoarthritis, and as the first-line choice in persons aged ≥75 years.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Osteoarthritis/complications , Pain Management/methods , Pain/etiology , Administration, Topical , Asian People , Consensus , Humans , Practice Guidelines as Topic , Treatment OutcomeABSTRACT
Report one case of patient with upper limb spasticity after traumatic brain injury treated at Rehabilitation Center, Bach Mai Hospital at September 2003. Results: muscle tone and pain decreased significantly by Dysport injections. This drug facilitated patient’s care, hygiene and exercises, and had no side-effect. However, this was the first case of Dysport therapy, and the time of follow-up still short (1 month), so this result was initial outcome. It is necessary to carry out a study with larger sample so that to have clear and definitive results.
